Skip to main content

Manage Myopia with ACUVUE® Abiliti™

A powerful approach to managing myopia.

Myopia is a silent epidemic affecting millions of children around the world—and it is growing fast1. It is the greatest eye health threat of the 21st century2. Research shows that myopia is more than just nearsightedness3. It is a chronic, progressive disease associated with an increased risk of significant complications later in life3-5 that threaten to take away our most treasured sense: Sight.

Our Commitment

Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this disease is our responsibility. We're determined to help you and your patients manage myopia with the latest research and tools, all while leading with science.We are doing it through our Abiliti™ portfolio. Our ultimate goal is to empower your patients to see their future.

Abiliti™ Approach

The Abiliti™ portfolio is about much more than just vision correction.It’s a comprehensive approach to managing myopia that will include:• Leading with science by continuing to generate new research and evidence• Increasing awareness of myopia as a disease which must be managed• Shaping the future of myopia by changing the trajectory of the disease• Empowering parents, patients, and eye care professionals through partnership, education, and advocacy• Offering a comprehensive portfolio of therapies and treatment support
Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this disease is our responsibility. We're determined to help you and your patients manage myopia with the latest research and tools, all while leading with science.We are doing it through our Abiliti™ portfolio. Our ultimate goal is to empower your patients to see their future.
Our Commitment

Our Commitment

Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this disease is our responsibility. We're determined to help you and your patients manage myopia with the latest research and tools, all while leading with science.We are doing it through our Abiliti™ portfolio. Our ultimate goal is to empower your patients to see their future.

Abiliti™ Approach

The Abiliti™ portfolio is about much more than just vision correction.It’s a comprehensive approach to managing myopia that will include:• Leading with science by continuing to generate new research and evidence• Increasing awareness of myopia as a disease which must be managed• Shaping the future of myopia by changing the trajectory of the disease• Empowering parents, patients, and eye care professionals through partnership, education, and advocacy• Offering a comprehensive portfolio of therapies and treatment support
Abiliti™ Approach

Our Commitment

Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson Vision believes that changing the trajectory of this disease is our responsibility. We're determined to help you and your patients manage myopia with the latest research and tools, all while leading with science.We are doing it through our Abiliti™ portfolio. Our ultimate goal is to empower your patients to see their future.

Abiliti™ Approach

The Abiliti™ portfolio is about much more than just vision correction.It’s a comprehensive approach to managing myopia that will include:• Leading with science by continuing to generate new research and evidence• Increasing awareness of myopia as a disease which must be managed• Shaping the future of myopia by changing the trajectory of the disease• Empowering parents, patients, and eye care professionals through partnership, education, and advocacy• Offering a comprehensive portfolio of therapies and treatment support

Why change the way you treat myopia?

In the past, eye care professionals saw myopia as a common vision problem, requiring vision correction only. Now, we know that myopia may lead to significant eye-health issues in adulthood3,6.When you become a member of the Johnson & Johnson Vision Master Your Abiliti™ Community, you'll have access to education, tools, and concierge support to set your practice up for managing myopia and driving patient outcomes.

Abiliti™ is a holistic solution built on three main pillars.

See Your Abiliti

Abiliti™ is a growing portfolio designed to manage myopia. Our goal is to develop products that give clearer vision today and better eye health in the future.In combination with the growing portfolio of Abiliti™ products, we offer a digital companion called SeeAbiliti™, a personalized mobile app that provides myopia-related lifestyle guidance such as increasing time spent outdoors.Download the SeeAbiliti™ App Now!Available on:Googleapp storeExplore our Abiliti™ portfolio

Master Your Abiliti

Johnson & Johnson Vision will provide you and your staff with digital and interactive educational tools along with communication insights to help you and your patients successfully navigate the myopia management journey.You’ll receive unparalleled and personalized concierge support, training, and education in managing myopia with Master Your Abiliti™ trainings through our clinical centers of excellence. Our evidence-based frameworks and hands-on training provide practical techniques to support you in having high-quality interactions with your patients and their parents. You will also have access to regular conferences, seminars, webinars, and white papers.Our team of myopia clinical consultants will provide you and your staff with intensive training on lens fitting and care, lifestyle interventions, practice management, marketing, and much more.It's all designed to help you and your patients feel confident that you're providing them with innovative options that adhere to the latest practices in myopia management.

Share Your Abiliti

Johnson & Johnson Vision believes that every child deserves the gift of clear sight. That’s why we’re committed to the ongoing Sight for Kids® program with our non-profit partner Lions Club International Foundation. And you can be part of this global effort.A 1-for-1 approach: Each annual purchase of an Abiliti™ product will provide a free comprehensive eye exam to a child in need through Sight for Kids®. An eye exam can detect over 270 different medical conditions6, including myopia, and is important in maintaining overall eye health.
Young Asian mother and daughter enjoying the outdoors, glasses-free, which is the goal of Abiliti™ myopia treatments.

With Abiliti™, the power is in your hands.

Together, we can take charge of myopia. Learn more about Johnson & Johnson Vision’s approach to clinical myopia management.
Eye doctor examining girl with opthalmoscope. Monitoring myopia is an important part of myopia treatment.

REFERENCES

1. Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M. and Rose, K.A., 2018. The epidemics of myopia: aetiology and prevention. Progress in retinal and eye research, 62, pp.134-149.
2. Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic – A Worldwide Economic and Social Model. Investigative ophthalmology & visual science. 2019;60(9):5466-5466.
3. Flitcroft DI The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research. 2012 31(6):622-660.
4. Donovan L, Sankaridurg P, Ho A et al Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
5. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
6. Systemic Conditions with Ocular and Visual Manifestations. American Optometric Association. December 2019.

PP2022ABLM4263
REFERENCES

REFERENCES

1. Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M. and Rose, K.A., 2018. The epidemics of myopia: aetiology and prevention. Progress in retinal and eye research, 62, pp.134-149.
2. Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic – A Worldwide Economic and Social Model. Investigative ophthalmology & visual science. 2019;60(9):5466-5466.
3. Flitcroft DI The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research. 2012 31(6):622-660.
4. Donovan L, Sankaridurg P, Ho A et al Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
5. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
6. Systemic Conditions with Ocular and Visual Manifestations. American Optometric Association. December 2019.

PP2022ABLM4263